Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      First: Health Ministry Panel wants JnJ to pay at least Rs 20 lakh to patients for faulty implants

      First: Health Ministry Panel wants JnJ to pay at least Rs 20 lakh to patients for faulty implants

      Ruby Khatun Khatun13 Jan 2018 4:07 PM IST
      New Delhi: Compensation has been recommended by a panel set up by the health ministry, in order to provide relief to patients who received faulty hip...
      Sun Pharma’s Halol facility gets clearance from Dutch drug regulator

      Sun Pharma’s Halol facility gets clearance from Dutch drug regulator

      Ruby Khatun Khatun13 Jan 2018 11:00 AM IST
      Mumbai: Sun Pharma, the largest pharma company by revenue and market share in India, has received a clearance for its Halol facility from a Dutch drug...
      Eyeing over 80 percent sales from US, India, Europe by 2021: Glenmark

      Eyeing over 80 percent sales from US, India, Europe by 2021: Glenmark

      Ruby Khatun Khatun13 Jan 2018 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals said it expects the US, Indian and European markets, along with active pharmaceutical ingredient (API) segment, to...
      HealthAssure to invest 15 million dollars to strengthen business

      HealthAssure to invest 15 million dollars to strengthen business

      Ruby Khatun Khatun13 Jan 2018 10:15 AM IST
      New Delhi: HealthAssure, a health-tech platform, said it will invest USD 15 million (over Rs 95 crore) over the next three years to strengthen its...
      Goa to refloat tenders for flagship medical insurance scheme

      Goa to refloat tenders for flagship medical insurance scheme

      Ruby Khatun Khatun13 Jan 2018 10:00 AM IST
      Panaji: The Goa government has decided to refloat tenders for its flagship medical insurance scheme that aims at providing cover to the entire...
      Health platforms initiate change in healthcare services

      Health platforms initiate change in healthcare services

      Ruby Khatun Khatun13 Jan 2018 9:45 AM IST
      New Delhi: The healthcare ecosystem in India is complex and huge. With the quality of healthcare services going up, the cost and complexity have...
      How biotech CEO John Hood turned failed Sanofi drug into multibillion deal

      How biotech CEO John Hood turned failed Sanofi drug into multibillion deal

      Ruby Khatun Khatun13 Jan 2018 9:30 AM IST
      In April 2016, John Hood went and told his wife that he had put down a quarter million dollars of their money to try and buy back a drug he’d helped...
      Radiology lab loses medical records of about 9,400 people

      Radiology lab loses medical records of about 9,400 people

      Ruby Khatun Khatun13 Jan 2018 9:15 AM IST
      FRAMINGHAM, Mass: A Massachusetts radiology lab says it has lost a portable hard drive that may contain the personal information and X-ray images of...
      Domestic medical device makers seek hike in basic custom duty

      Domestic medical device makers seek hike in basic custom duty

      Ruby Khatun Khatun12 Jan 2018 11:00 AM IST
      New Delhi: The government needs to increase the basic customs duty on medical devices in the range of 5-15 percent to promote domestic manufacturing,...
      More trouble for Sanofi: Philippines exhumes bodies of two children in dengue vaccine probe

      More trouble for Sanofi: Philippines exhumes bodies of two children in dengue vaccine probe

      Ruby Khatun Khatun12 Jan 2018 10:45 AM IST
      MANILA: A Philippine government agency on Thursday exhumed the bodies of two children whose parents suspect they died of dengue after receiving a new...
      FDA approves Senza II Spinal Cord Stimulation System delivering HF10 therapy

      FDA approves Senza II Spinal Cord Stimulation System delivering HF10 therapy

      Ruby Khatun Khatun12 Jan 2018 10:30 AM IST
      REDWOOD CITY, Calif: Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...
      Roche plea in HC on cancer drug not maintainable: Biocon, Mylan

      Roche plea in HC on cancer drug not maintainable: Biocon, Mylan

      Ruby Khatun Khatun12 Jan 2018 10:27 AM IST
      New Delhi: Generic drug makers Biocon and Mylan told the Delhi High Court that Swiss pharma major Roche's civil suit, challenging DCGI approvals...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok